Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 231

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

Open access
Chaturvedi, Shruti, Braunstein, Evan M., Yuan, Xuan, Yu, Jia, Alexander, Alice, Chen, Hang, Gavriilaki, Eleni, Alluri, Ravi, Streiff, Michael B., Petri, Michelle, Crowther, Mark A., McCrae, Keith R., Brodsky, Robert A. · 2020 · Blood

Abstract

The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies, including anti-β2-glycoprotein-I (anti-β2GPI), that are considered central to APS pathogenesis. Based on animal studies showing a role of complement in APS-related clinical events, we used the modified Ham (mHam) assay (complement-dependent cell killing) and cell-surface deposition of C5b-9 to test the hypothesis that complement activation is associated with thrombotic events in APS. A positive mHam (and corresponding C5b-9 deposition) were present in 85.7% of catastrophic APS (CAPS), 35.6% of APS (and 68.5% of samples collected within 1 year of thrombosis), and only 6.8% of systemic lupus erythematosus (SLE) sera. A positive mHam assay was associated with triple positivity (for lupus anticoagulant, anticardiolipin, and anti-β2GPI antibodies) and recurrent thrombosis. Patient-derived anti-β2GPI antibodies also induced C5b-9 deposition, which was blocked completely by an anti-C5 monoclonal antibody, but not by a factor D inhibitor, indicating that complement activation by anti-β2GPI antibodies occurs primarily through the classical complement pathway. Finally, patients with CAPS have high rates of rare germline variants in complement regulatory genes (60%), compared with patients with APS (21.8%) or SLE (28.6%) or normal controls (23.3%), and have mutations at a rate similar to that of patients with atypical hemolytic uremic syndrome (51.5%). Taken together, our data suggest that anti-β2GPI antibodies activate complement and contribute to thrombosis in APS, whereas patients with CAPS have underlying mutations in complement regulatory genes that serve as a “second hit,” leading to uncontrolled complement activation and a more severe thrombotic phenotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2019003863

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 231

Metadata

Authors
Chaturvedi, S., Braunstein, E. M., Yuan, X., Yu, J., Alexander, A., Chen, H., Gavriilaki, E., Alluri, R., Streiff, M. B., Petri, M., Crowther, M. A., McCrae, K. R., & Brodsky, R. A.
Venue
Blood
Published
2020-01-23
Volume
135
Issue
4
Pages
239-251
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2992307477
Cited by
231
References
8
FWCI
17.36
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. https://app.cochat.ai/papers/10.1182/blood.2019003863
The paper
Chaturvedi, S., Braunstein, E. M., Yuan, X., Yu, J., Alexander, A., Chen, H., Gavriilaki, E., Alluri, R., Streiff, M. B., Petri, M., Crowther, M. A., McCrae, K. R., & Brodsky, R. A. (2020). Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. Blood. https://doi.org/10.1182/blood.2019003863

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.